Education
About Us
Working with TipRanks
Follow Us
Lemaitre Vascular (DE:LHU)
FRANKFURT:LHU
Earnings Data
Report Date
Jul 24, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.5Last Year’s EPS
0.46Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 01, 2025
|% Change Since: -23.73%
|Next Earnings Date:Jul 24, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong sales performance, successful international expansion, and robust financial health. However, challenges such as tariff impacts and increased operating expenses were noted. The positive developments, particularly the increased sales guidance and international growth, outweigh the lowlights, indicating resilience and growth potential.Company Guidance
In the LeMaitre Vascular Q1 2025 earnings call, the company revised its full-year sales guidance upward to $245 million from the previous $239 million, driven by a strong 13% organic sales growth compared to the prior guidance of 10%. The growth was propelled by increased sales across all product categories, including a 17% rise in grafts and a 14% increase in carotid shunts. Geographically, EMEA sales surged by 18%, while the Americas and APAC saw increases of 11% and 3%, respectively. LeMaitre also expanded its salesforce, aiming to reach 170 representatives by year-end, up from the current 164, and is bolstering its international presence with new sales offices. The gross margin for Q1 was 69.2%, slightly up from the previous year, driven primarily by a 9% increase in average selling prices. Operating income grew by 6% year-over-year to $12.6 million, resulting in an operating margin of 21%. The company also highlighted its strategic optionality with $303 million in cash, despite challenges such as tariffs and the cessation of its Elutia distribution agreement impacting its financial outlook.Strong Sales Performance
Q1 sales were stronger than February 27 guidance with 13% organic growth and 12% reported growth. Record sales were achieved in all five categories: graphs, carotid shunts, catheters, velvet homes, and patches.
International Expansion and Regulatory Success
Established new international sales offices and received MDR CE mark for autographs. European launch imminent with additional approvals expected in Australia, Canada, Singapore, and Korea by H1 2026.
Increased Sales Guidance
Raised 2025 reported sales guidance to $245 million from $239 million. Organic sales guidance increased to 13% from 10%.
Strong Financial Position
Ended Q1 with $302.5 million in cash and securities, providing strategic optionality. Cash from operations generated $9 million in the quarter.
Positive Price and Volume Dynamics
Organic sales growth driven by 9% average selling price increases and 4% unit increases. Gross margin improved by 60 basis points year over year.
DE:LHU Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:LHU Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 27, 2025 | €97.02 | €90.56 | -6.67% |
Oct 31, 2024 | €80.97 | €89.92 | +11.04% |
Aug 01, 2024 | €78.83 | €80.32 | +1.89% |
May 02, 2024 | €60.85 | €60.85 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Lemaitre Vascular (DE:LHU) report earnings?
Lemaitre Vascular (DE:LHU) is schdueled to report earning on Jul 24, 2025, TBA Not Confirmed.
What is Lemaitre Vascular (DE:LHU) earnings time?
Lemaitre Vascular (DE:LHU) earnings time is at Jul 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Lemaitre Vascular stock?
The P/E ratio of Lemaitre Vascular is N/A.
What is DE:LHU EPS forecast?
DE:LHU EPS forecast for the fiscal quarter 2025 (Q2) is 0.5.